מהיסוד לפסגה – חידושים בתוספי ויטמינים ומינרלים
האם יש יתרון לצריכת פולאט על פני חומצה פולית? מדוע מוסיפים אשלגן לתוספי מגנזיום? האם ברזל הנתון בליפוזום באמת משנה את כללי המשחק באנמיה?
ת. פרסום:
ת. עדכון אחרון:
זמן צפייה:
1 דקות
מקורות:
References:
2. Mehta BC. Ineffectiveness of iron polymaltose in treatment of iron deficiency anemia. J Assoc Physicians India 2003; 51:419-421
3. Mehta BC. Iron hydroxide polymaltose–cause of persistent iron deficiency anemia at delivery. Indian J Med Sci 2001; 55:616-620
4. Malhotra S, Garg SK, Khullar GK. Kinetics of two different iron formulations and their effect on diurnal variation of serum iron levels. Methods Find Exp Clin Pharmacol 2004; 26:417-420
5. Indriolo A, Et al. Comparison between Liposomal Iron and Ferrous sulfate in patients with iron deficiency anemia and inflammatory bowel disease. Digestive Disease Week (DDW). Chicago 2014
6. Pisani, Et al. Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anemia in CKD patients; a randomized trial Nephrol Dial Transplant. 2015;30:645-652
7. POSITION STATEMENT: Folate and neural tube defects. The role of supplements and food fortification. Paediatr Child Health 2016;21(3):145-49
8. Harshman MR, Aldoori W. Folic acid and prevention of neural tube defects. Can Fam Physician. 2008 Jan; 54(1): 36–38.
9. Grosse SD, Collins JS. Folic acid supplementation and neural tube defect recurrence prevention. Birth Defects Res A Clin Mol Teratol. 2007 Nov;79(11):737-42.
10. האיגוד הישראלי למיילדות וגינקולוגיה: נייר עמדה מס' 29 – תוספי תזונה והרגלים בהריון
דצמבר 2013
11. Capel I, Corcoy C. What Dose of Folic Acid Should Be Used for Pregnant Diabetic Women? Diabetes Care 2007 Jul; 30(7): e63-e63.
12. Patanwala I, King MJ, Barrett DA, Rose J, Jackson R, Hudson M, Philo M, Dainty JR, Wright AJ, Finglas PM, Jones DE. Folic acid handling by the human gut: implications for food fortification and supplementation. Am J Clin Nutr. 2014 Aug;100(2):593-9.
13. Boilson A, Staines A, Kelleher CC, Daly L, Shirley I, Shrivastava A, Bailey SW, Alverson PB, Ayling JE, McDermott AP, MacCooey A, Scott JM, Sweeney MR. Unmetabolized folic acid prevalence is widespread in the older Irish population despite the lack of a mandatory fortification program. Am J Clin Nutr. 2012 Sep;96(3):613-21.
14. Nhui Q, Yimin C , Lin S , Ningling S, Yan Z, Jianping L, Xin X, Binyan W, Xiping X, Yong H Xiaobin W. Folic acid supplementation and cancer risk: A meta-analysis of randomized controlled trials. Int. J. Cancer 2013: 133, 1033–1042
15. Vollset SE, Clarke R, Lewington S, Ebbing M, Halsey J, Lonn E, Armitage J, Manson JE, Hankey GJ, Spence JD, Galan P, Bønaa KH, Jamison R, Gaziano JM, Guarino P, Baron JA, Logan RF. Effects of folic acid supplementation on overall and site-specifi c cancer incidence during the randomised trials: meta-analyses of data on 50 000 individuals. Lancet 2013; 381: 1029–36
16. Mackerras D, Tan J, Larter C. Folic Acid, Selected Cancers and All-cause Mortality: A Meta-analysis. Int Food Risk Anal J, 2014, 4:1
17. Taylor CM, Atkinson C, Penfold C, Bhattacharya S, Campbell D, Smith GD, Leary S, Ness A.
Folic acid in pregnancy and mortality from cancer and cardiovascular disease: further follow-up of the Aberdeen folic acid supplementation trial. J Epidemiol Community Health 2015;0:1–6
18. Riddell LJ, Chisholm A, Williams S, Mann JI. Dietary strategies for lowering homocysteine concentrations. Am J Clin Nutr. 2000 Jun;71(6):1448-54.
19. Spence JD. B vitamin therapy for homocysteine: renal function and vitamin B12 determine cardiovascular outcomes. Clin Chem Lab Med. 2013 Mar 1;51(3):633-7.
20. Kieboom BC, Niemeijer MN, Van den Berg ME, Franco OH, Deckers JW, Hofman A, Zietse R, Stricker BH, Hoorn EJ. Serum Magnesium and the Risk of Death From Coronary Heart Disease and Sudden Cardiac Death. J Am Heart Assoc. 2016 Jan; 5 (1).
21. Nriagu J, Darroudi F, Shomar B. Health effects of desalinated water: Role of electrolyte disturbance in cancer development. Environ Res. 2016 Oct;150:191-204
22. Huang CL, Kuo E. Mechanism of Hypokalemia in Magnesium Deficiency. J Am Soc Nephrol 2007; 18: 2649 –2652
23. Pere AK, Lindgren L, Tuomainen P, Krogerus L, Rauhala P, Laakso J, Karppanen H, Vapaatalo H, Ahonen J, Mervaala EM. Dietary potassium and magnesium supplementation in cyclosporine-induced hypertension and nephrotoxicity. Kidney Int. 2000 Dec;58(6):2462-72.
24. Lindberg JS, Zobitz MM, Poindexter JR, Pak CY. Magnesium bioavailability from magnesium citrate and magnesium oxide. J Am Coll Nutr. 1990 Feb;9(1):48-55.
25. Walker AF, Marakis G, Christie S, Byng M. Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study. Magnes Res. 2003 Sep;16(3):183-91.
26. Kappeler D , Heimbeck I , Herpich C , Naue N , Höfler J , Timmer W, Michalke B. Higher bioavailability of magnesium citrate as compared to magnesium oxide shown by evaluation of urinary excretion and serum levels after single-dose administration in a randomized cross-over study. BMC Nutrition 2017 January; 3:7
27. Shechter M, Saad T, Shechter A, Koren-Morag N, Silver BB, Matetzky S. Comparison of magnesium status using X-ray dispersion analysis following magnesium oxide and magnesium citrate treatment of healthy subjects. Magnes Res. 2012 Mar 1;25(1):28-39